Your browser doesn't support javascript.
loading
Developing Disease-Modifying Treatments in Alzheimer's Disease - A Perspective from Roche and Genentech.
Doody, R.
Affiliation
  • Doody R; R. Doody on behalf of the Roche/Genentech Alzheimer's Molecule and Diagnostics Teams Product Development, Neuroscience, F. Hoffman-La Roche Ltd, Basel, Switzerland, rachelle.doody@roche.com, Tel: +41 61 687 09 46.
J Prev Alzheimers Dis ; 4(4): 264-272, 2017.
Article in En | MEDLINE | ID: mdl-29181492
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease Type of study: Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: J Prev Alzheimers Dis Year: 2017 Document type: Article Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease Type of study: Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: J Prev Alzheimers Dis Year: 2017 Document type: Article Country of publication: Suiza